http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20000002087-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebda704055f6b3783ed71a29b7591529 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-733 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate | 1998-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac4258d22640d3cbc90e55db7fef3372 |
| publicationDate | 2000-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20000002087-A |
| titleOfInvention | Novel use of inulin as an anticancer agent and pharmaceutical composition comprising the active ingredient |
| abstract | The present invention relates to a novel use of inulin as an anticancer agent and a pharmaceutical composition having the same as an active ingredient.n n n The present invention demonstrates the ability of inulin to produce nitric oxide and inulin-induced nitric oxide synthase expression, and demonstrates the ability of inulin to produce nitric oxide, and also measures the ability to produce tumor necrosis factor-α related to anticancer effects. By identifying the ability to inhibit inducible nitric oxide production, it has an excellent effect in providing a new use as an anticancer agent. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017044393-A1 |
| priorityDate | 1998-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.